StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Monday. The brokerage issued a hold rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Performance

MLSS opened at $1.12 on Monday. Milestone Scientific has a fifty-two week low of $0.54 and a fifty-two week high of $1.27. The company has a fifty day moving average of $0.87 and a two-hundred day moving average of $0.90. The stock has a market capitalization of $87.34 million, a price-to-earnings ratio of -16.02 and a beta of 1.10.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.75% of the stock is owned by corporate insiders.

Institutional Trading of Milestone Scientific

Several institutional investors have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific during the third quarter worth about $48,000. World Investment Advisors LLC acquired a new position in Milestone Scientific during the third quarter worth about $91,000. Carnegie Investment Counsel boosted its position in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after acquiring an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.